A rating of 92 puts Prelude Therapeutics Inc (PRLD) near the top of the Biotechnology industry according to InvestorsObserver. Prelude Therapeutics Inc's score of 92 means it scores higher than 92% of stocks in the industry. Prelude Therapeutics Inc also received an overall rating of 80, putting it above 80% of all stocks. Biotechnology is ranked 19 out of the 148 industries.
PRLD has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on PRLD!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 80 would rank higher than 80 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Prelude Therapeutics Inc Stock Today?
Prelude Therapeutics Inc (PRLD) stock is trading at $5.78 as of 12:12 PM on Tuesday, May 30, a rise of $0.25, or 4.52% from the previous closing price of $5.53. The stock has traded between $5.62 and $5.85 so far today. Volume today is less active than usual. So far 32,312 shares have traded compared to average volume of 102,880 shares.
Click Here to get the full Stock Report for Prelude Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter